Figure 1 | Scientific Reports

Figure 1

From: A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma

Figure 1

Selected images from a patient with a distal oesophageal adenocarcinoma. Maximum intensity projection (MIP) (a) and fused axial PET-CT images (b) demonstrated a large FDG-avid tumour. After neo-adjuvant chemotherapy was completed, a repeat PET-CT (c, d) showed there had been an excellent metabolic response. This patient had a positive DDIR assay and final pathological examination indicated a good response (tumour regression grade 2).

Back to article page